Inhaled Cannabis Linked to Fewer Premature Heartbeats

Key Points

• • Habitual cannabis users had about 9% fewer premature heartbeats on days they inhaled cannabis than on abstinence days.
  • The reduction primarily involved premature atrial contractions (PACs), rather than premature ventricular contractions (PVCs).
  • Researchers caution that the findings reflect acute effects and do not establish that cannabis improves cardiovascular health.
  • Continuous ECG monitoring in a randomized crossover design provided a more direct assessment of heart rhythm than prior observational studies.
  • For More Updates in Cardiology, register for the ISCC 2026 CME Conference

Randomized Trial Challenges Assumptions About Inhaled Cannabis and Heart Rhythm

Inhaled cannabis was associated with a modest reduction in premature heartbeats among habitual users in a randomized crossover study led by researchers at the University of California, San Francisco (UCSF). The findings add complexity to the evidence surrounding cannabis and cardiovascular health and highlight why randomized research can produce results that differ from observational data.

The study included 108 adults who regularly smoked or vaped cannabis and had no clinically diagnosed cardiac arrhythmias. Participants alternated between cannabis use and abstinence days over 14 days while wearing continuous ECG, activity, sleep, and glucose monitors. The case-crossover approach allowed researchers to compare each participant with themselves, reducing the influence of individual differences.

PACs Declined, While PVCs Remained Unchanged

The researchers observed a statistically significant reduction in cardiac ectopy, driven primarily by fewer premature atrial contractions (PACs). No significant difference emerged in premature ventricular contractions (PVCs).

PACs are early heartbeats originating in the atria and are common in clinical practice. Their frequency can provide information about future atrial fibrillation risk, while PVC burden has been associated with ventricular dysfunction and heart failure risk. The trial’s continuous ECG monitoring allowed investigators to capture these rhythm changes in real time rather than relying on medical records or participant recall.

Researchers also found no significant differences in daily activity, sleep duration, or glucose levels between cannabis-use and abstinence days. The study was designed to examine short-term physiological effects, not long-term cardiovascular outcomes.

What the Findings About Inhaled Cannabis Mean for Cardiovascular Care

The results should not be interpreted as evidence that cannabis protects the heart or reduces arrhythmia risk. Instead, they raise questions about the biological mechanisms that influence premature atrial contractions and demonstrate the value of controlled research into cannabis use and heart rhythm.

For More Updates in Cardiology, register for the ISCC 2026 CME Conference

For cardiologists, nurses, and other healthcare professionals, the findings reinforce the importance of separating acute physiological observations from long-term clinical outcomes. The UCSF MARY-JANE trial was specifically designed to assess whether inhaled cannabis changes the frequency of premature atrial and ventricular contractions; its broader cardiovascular implications require further investigation.

Source:

University of California – San Francisco